elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28659468-1652B86B-31F1-40A7-8DA0-5F777FB57984
Q28659468-1652B86B-31F1-40A7-8DA0-5F777FB57984
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28659468-1652B86B-31F1-40A7-8DA0-5F777FB57984
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
P2860
Q28659468-1652B86B-31F1-40A7-8DA0-5F777FB57984
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28659468-1652B86B-31F1-40A7-8DA0-5F777FB57984
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e30a6a647d5f76957e298e5d075815fd841a6a25
P2860
End points and United States Food and Drug Administration approval of oncology drugs.